Stryker anticipates 6.5% to 7% organic net sales growth in 2026 and plans to scale Versius in the U.S.

Summary

Stryker anticipates 6.5% to 7% organic net sales growth in 2026 and plans to scale its Versius surgical robot in the U.S., according to a Seeking Alpha breaking news headline published on October 30, 2026. The source's summary field was empty, so this account rests on the headline alone and gives no further detail.

Timeline

1. Seeking Alpha

   30 Oct 2026, 01:39 UTCSource ↗

   Seeking Alpha reports that Stryker anticipates 6.5% to 7% organic net sales growth in 2026 as it plans to scale Versius in the U.S.